HCPCS Code Details - Q5119

HCPCS Level II Code
Miscellaneous Services (Temporary Codes)
HCPCS Code Q5119

Long description:
Injection, rituximab-pvvr, biosimilar, (ruxience), 10 mg

Short description:
Inj ruxience, 10 mg

HCPCS Modifier1
HCPCS Pricing indicator 51 - Drugs
Multiple pricing indicator A - Not applicable as HCPCS priced under one methodology
Coverage code C - Carrier judgment
BETOS2 code O1D - Chemotherapy
HCPCS Action code A - Add procedure or modifier code
Type of service 1 - Medical care
Effective date Effective Jul 01, 2020
Date added Added Jul 01, 2020
HCPCS Coding Procedures

HCPCS Modifiers

In HCPCS Level II, modifiers are composed of two alpha or alphanumeric characters.

Example: E0260-NU - Hospital bed, semi-electric (head and foot adjustment), with any type side rails, with mattress
NU” identifies the hospital bed as new equipment

ASP Drug pricing - Q5119

Effective Code Dosage Payment
Vaccine AWP % Vaccine Limit Infusion AWP % DME infusion limit Blood AWP % Blood limit Clotting factor Note
July 1, 2020 - September 30, 2020 10 MG 73.83 - - - - - -

See also

  • HCPCS Q5118 · Injection, bevacizumab-bvzr, biosimilar, (zirabev), 10 mg

  • HCPCS Q5120 · Injection, pegfilgrastim-bmez, biosimilar, (ziextenzo), 0.5 mg

1 Two-digit numeric codes are Level I code modifiers copyrighted© by the American Medical Association's Current Procedural Terminology (CPT).

2 BETOS stands for “Berenson-Eggers Type Of Service”